You are using an older browser version. Please use a supported version for the best MSN experience.

Insulin makers grilled on price surge, as diabetics struggle to afford life-saving meds

Pressure from Congress appears to be spurring the pharmaceutical industry to lower prescription drug prices for some patients. One of the main producers of insulin, Sanofi, said it will cap the cost of the life-saving drug for diabetics. Some could save thousands of dollars a year. Anna Werner reports.



Editor's Picks


Featured Partners

image beaconimage beaconimage beacon